MTOR signaling regulates microglia metabolism and survival via 4E‐BP‐controlled mRNA translation

Abstract

AbstractBackgroundRare loss‐of‐function variants in TREM2 (Triggering Receptor Expressed in Myeloid cells 2) are associated with an increased risk of AD. There are ongoing efforts to therapeutically boost microglial neuroprotective functions by targeting TREM2. However, the intracellular mechanisms underlying these functions in AD are not fully understood. TREM2 signaling maintains metabolic fitness through activation of the mechanistic target of rapamycin (mTOR) allowing microglia to sustain their metabolism during amyloidosis (Ulland et al., 2017). Detrimental decreases in microglial mTOR signalling during amyloidosis independent of TREM2 loss‐of‐function has also been reported (Baik et al., 2019).The mTOR pathway acts upstream of the eukaryotic mRNA translation by suppressing the translation repressor, eukaryotic translation initiation factor 4E (eIF4E)‐binding proteins (4E‐BPs). mTOR inhibits the 4E‐BPs via phosphorylation, thereby releasing eIF4E and allowing mRNA translation to initiate (Hay and Sonenberg, 2004). Work from our group demonstrated that mTOR boosts mitochondrial metabolism through 4E‐BP‐controlled mRNA translation (Morita et al., 2013). Therefore, we aimed to understand the dysregulated mechanisms at the intersection of mTOR‐controlled mRNA translation and metabolism in microglia response to Amyloid‐β (Aß).MethodWe used immunoblotting to investigate the effect on 4E‐BP phosphorylation following chronic exposure to Aß aggregates and TREM2 signaling inhibition in a microglia cell line. We manipulated the mTOR pathway by knocking out the downstream effectors, 4E‐BPs, to promote the translation of 4E‐BP‐controlled mRNAs in microglia in vitro and in vivo. We crossed the microglia‐specific 4E‐BPs knock out mouse with a RiboTag mouse to pull‐down ribosome‐bound mRNAs, providing a genome‐wide pool of actively translating mRNAs (the translatome) in the absence of 4E‐BPs in microglia.ResultWe showed that 4E‐BP‐controlled mRNA translation is inhibited upon chronic exposure to Aß or TREM2 signaling inhibition. The deletion of 4E‐BPs in microglia in‐vitro leads to a decrease in expression of pro‐inflammatory mediators and microglia cell death, and an increase in reliance on oxidative phosphorylation upon exposure to Aß. We also observed that 4E‐BP deletion changes the microglia translatome and decreases expression of inflammatory mediators in vivo after an intracranial Aß infusion.ConclusionWe conclude that mTOR signaling exerts key effects on microglia function and metabolism through 4E‐BP‐controlled mRNA translation.